NASDAQ:RAPP | Income Statement | Rapport Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$0.00$51.41M$9.39M$60.81M-$60.81M$4.19M-$56.62M-$1.19-$1.1947,473,17447,473,174
2026-03-31$20M$32.72M$11.5M$44.22M-$24.22M$4.36M-$19.86M-$0.42-$0.4247,236,61847,236,618
2025-12-31$30.26M$38.51M-$38.51M$4.75M-$33.76M-$0.71-$0.712,710,6822,710,682
2025-09-30$22.28M$29.99M-$29.99M$3.06M-$26.93M-$0.71-$0.7137,931,17037,931,170
2025-06-30$0.00$22.68M$6.82M$29.5M-$29.5M$2.76M-$26.73M-$0.75-$0.7535,444,63535,444,635
2025-03-31$0.00$19.57M$7.54M$27.11M-$27.11M$3.05M-$24.06M-$0.68-$0.6835,266,57735,266,577
2024-12-31$17.2M$23.52M-$23.52M$3.54M-$19.98M-$19.98M-$0.12-$0.124,812,5614,812,561
2024-09-30$15.54M$21.64M-$21.64M$4.1M-$17.54M-$17.54M-$0.50-$0.5034,855,90734,855,907
2024-06-30$15.69M$20.8M-$20.8M$2.68M-$18.12M-$18.12M-$1.70-$1.7010,666,52810,666,528
2024-03-31$12.5M$17.09M-$17.09M-$5.58M-$22.67M-$11.07-$11.072,046,8892,046,889
2023-12-31$11.8M$14.79M-$14.79M$1.28M-$13.51M$6,000.00-$13.52M-$8.38-$8.3861,10861,108
2023-09-30$7.58M$9.56M-$9.56M$856,000.00-$8.71M$1,000.00-$8.71M-$5.70-$5.701,529,2161,529,216
2023-06-30$4.72M$6.63M-$6.63M$221,000.00-$6.41M$2,000.00-$6.41M-$4.45-$4.451,440,1091,440,109
2023-03-31-$6.15M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$94.79M$125.1M-$125.1M$13.62M$0.00-$111.48M-$2.86-$2.8638,934,56938,934,569
2024-12-31$60.94M$83.06M-$83.06M$4.75M-$78.31M$0.00-$78.31M-$3.78-$3.7820,738,33820,738,338
2023-12-31$28M$36.18M-$36.18M$1.4M-$34.78M$10,000.00-$34.79M-$23.10-$23.101,505,7741,505,774

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.